Skip to content
case study
CLINICAL CASE: GROUP OF FEMALE PATIENTS WITH ANDROGENETIC ALOPECIA
Treated with RestaX Woman 30cpr and RestaX Woman Lotion
Medical Surgeon
Specialist in Dermatology and Venereology
Expert in Trichology and PRP
The patients followed during this clinical trial are a group of women with ages ranging from 29 to 80 years and suffering from androgenetic alopecia. Most had average follicular density and hair diameter of medium satisfaction and a positive pull test.
After three months of therapy with Restax Woman 30cps e Restax Women’s Lotion significant improvement in the above parameters was shown, and the patients were quite satisfied and motivated in continuing the prescribed therapies.
Dr. Ivana Concetta Patti
Share the article on your socials!
Stay up to date*, sign up for our Science Newsletter to receive every article on your email!
You may also be interested in.
-
STUDIO SU UN NUTRACEUTICO ED UNA LOZIONE FITOTERAPICA IN DONNE CON ALOPECIA FEMMINILE POST-MENOPAUSA -
THE USE OF GINKGO BILOBA EXTRACT IN THE TREATMENT OF CHRONIC FATIGUE SYNDROME -
ON THE USE OF SPECIFIC NUTRACEUTICALS AS ADJUNCTS TO TREATMENTS FOR ADHD -
THEY TALK ABOUT TRIVIS UV ON “THE SKIN” -
ON THE BENEFITS OF HYALURONIC ACID ON SCALP AND FOLLICLES
Products in this article:
Restax Woman 30cps
Restax Donna is a product with Agnocasto, designed and developed for female alopecia of childbearing age
RestaX Women's Lotion
RestaX Women's Lotion is specifically for the treatment of telogen effluvium from stress and seasonal change fall in women.
